SI-BONE, Inc. (NASDAQ: SIBN) is carving a niche in the healthcare sector, specifically within the medical devices industry. Headquartered in Santa Clara, California, this company engages in developing innovative procedural..
Kura Oncology, Inc. (NASDAQ: KURA) stands out in the biotechnology sector as a promising clinical-stage biopharmaceutical company dedicated to developing innovative cancer treatments. With a market capitalization of $740.52 million,..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, California, is drawing considerable attention from investors, given its robust pipeline of immunology therapeutics and the potential for..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) continues to capture the attention of investors in the biotechnology sector, largely due to its potential upside of 10.64%. With a market cap of..
For investors eyeing the healthcare sector, SIGA Technologies Inc. (NASDAQ: SIGA) presents a unique opportunity. With a market cap of $446.85 million, this American-based company operates within the niche domain..
Investors eyeing the healthcare sector would do well to tune into Oruka Therapeutics, Inc. (NASDAQ: ORKA), a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for psoriasis and other inflammatory..
MBX Biosciences, Inc. (MBX) has captured the attention of investors with a compelling potential upside of 94.37%, according to the latest analyst ratings. This clinical-stage biopharmaceutical company, headquartered in Carmel,..
Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company headquartered in New Haven, Connecticut, is at the forefront of developing innovative therapies aimed at degrading disease-causing proteins. The company’s pioneering work..
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, is garnering significant attention within the biotechnology sector. This intriguing company is focused on pioneering T cell redirecting..
In the dynamic realm of healthcare, Standard BioTools Inc. (NASDAQ: LAB) emerges as a noteworthy player within the medical devices industry, a sector known for its rapid innovation and transformative..
Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based biotechnology company, is garnering significant attention from investors, thanks to its innovative T cell therapies aimed at combating cancer and autoimmune diseases. With..
AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the healthcare sector, is navigating a complex landscape with its technology-enabled workforce solutions. Headquartered in Dallas, Texas, AMN has carved..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the intersection of innovation and uncertainty within the biotechnology landscape. Specializing in cell engineering and biosecurity, the Boston-based company is forging pathways..
Sionna Therapeutics, Inc. (NASDAQ: SION), a burgeoning name in the biotechnology sector, is capturing investor attention with a significant potential upside of 42.10%. Specializing in the development of treatments for..
Niagen Bioscience, Inc. (NASDAQ: NAGE) is emerging as a noteworthy player in the biotechnology sector, specifically within the healthcare industry. With its focus on developing innovative healthy aging products, Niagen..
Tilray Brands, Inc. (NASDAQ: TLRY) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. This Canadian-based company has been navigating the evolving landscape of..
For investors scanning the volatile biotech sector, GH Research PLC (NASDAQ: GHRS) offers a compelling proposition. This Dublin-based clinical-stage biopharmaceutical company, currently valued at $940.99 million, is making significant strides..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is drawing significant attention from investors, thanks to its impressive potential upside and robust pipeline in the biotechnology sector. With a market capitalization of $1.9..
For investors with an eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) presents a compelling opportunity, particularly given its potential upside of 46.14% based on analyst target prices. This..
Sonida Senior Living, Inc. (SNDA) stands as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $680.59 million, the company..
